Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium SCHEMBL29365565 | 0.86 | LMNA (0.42) | ESR1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7175016 | 0.86 | ESR1 (0.41) | ESR1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL7183332 | 0.85 | KCNK9 (0.40) | ESR1LMNASMN1; SMN2MAPTKMT2A | |
| SCHEMBL27651 | 0.84 | LMNA (0.43) | ESR1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27967065 | 0.84 | LMNA (0.43) | ESR1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15158 | 0.84 | LMNA (0.40) | ESR1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7177683 | 0.83 | KMT2A (0.38) | ESR1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL25408502 | 0.83 | LMNA (0.42) | ESR1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17376918 | 0.83 | LMNA (0.42) | ESR1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL18334662 | 0.83 | LMNA (0.42) | ESR1LMNANPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025124047-A1 | PHOTOSENSITIVE THERMOSETTING RESIN COMPOSITION, DRY FILM, CURED PRODUCT, AND ELECTRONIC COMPONENT COMPRISING CURED PRODUCT | 太阳油墨（苏州）有限公司 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025066478-A1 | MELAMINE-FREE ALKALINE DEVELOPABLE RESIN COMPOSITION, DRY FILM, CURED PRODUCT AND ELECTRONIC COMPONENT HAVING SAID CURED PRODUCT | 太阳油墨（苏州）有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-118043739-A | Photosensitive resin composition, cured product, printed wiring board, and method for producing printed wiring board | 太阳控股株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-11912800-B2 | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| EP-3861002-B1 | ORGANOSILICON COMPOUND, METHOD FOR PRODUCING THEREOF, AND USE THEREOF | DOW TORAY CO LTD (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-11385541-B2 | Radiation-curable resin composition and production method thereof | CENTRO TECNOLOGICO DE NANOMATERIALES AVANZADOS, S.L. (ES) | 2022-07-12 | — | — | US | disclosed |
| WO-2020072269-A1 | ORGANOSILICON COMPOUND, METHOD FOR PRODUCING THEREOF, AND USE THEREOF | DOW TORAY CO., LTD. (JP) | 2020-04-09 | — | — | WO | disclosed |
| US-10040916-B2 | Functional polymer membrane and method for producing same | FUJIFILM CORPORATION (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20180044545-A1 | PHOTOCURABLE INKS FOR INDIRECT PRINTING METHOD | XEROX CORPORATION | 2018-02-15 | — | — | US | disclosed |
| US-9795955-B2 | Curable composition and cured polymer product | FUJIFILM CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20070021522-A1 | for protecting xerographic images on substrates subjected to abrasives, heat, and/or sunlight since the compositions protect such images from cracking, fading, and smearing; silicone oil as release agent | XEROX CORPORATION (US) | 2007-01-25 | — | — | US | disclosed |
| US-7166406-B2 | Prevention or reduction of thermal cracking on toner-based prints | XEROX CORPORATION (US) | 2007-01-23 | — | — | US | disclosed |
| US-20070007698-A1 | Method of producting three-dimensional model | FUJIFILM CORPORATION (JP) | 2007-01-11 | — | — | US | disclosed |
| US-20070007698-A1 | Method of producting three-dimensional model | FUJIFILM CORPORATION (JP) | 2007-01-11 | — | — | US | disclosed |
| CN-1200943-C | Organometallic acyl-aryl phosphine | CIBA SC HOLDING AG (CH) | 2005-05-11 | — | — | CN | disclosed |
| US-6579663-B2 | Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-06-17 | — | — | US | disclosed |
| US-20020107413-A1 | Organometallic monoacylarylphosphines | WOLF JEAN-PIERRE (CH) | 2002-08-08 | — | — | US | disclosed |
| US-6399805-B2 | SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-06-04 | — | — | US | disclosed |
| US-20010031898-A1 | Organometallic monoacylarylphosphines | CIBA SPECIALTY CHEMICALS CORP. | 2001-10-18 | — | — | US | disclosed |
| CN-1308081-A | Organometallic acyl-aryl phosphine | CIBA SC HOLDING AG (CH) | 2001-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107413-A1 | Organometallic monoacylarylphosphines | CBR1, NAF1, DHCR24 | ESR1 3736/4885LMNA 3241/4885NPC1 772/4885 |
| US-20010031898-A1 | Organometallic monoacylarylphosphines | NAF1, DHCR24, CBR1 | ESR1 3621/4885LMNA 3247/4885NPC1 872/4885 |
| US-11912800-B2 | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses | CRYAA, UACA, CRYAB | ESR1 3064/4885LMNA 1459/4885NPC1 4695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.